Conference Reports for NATAP

Back

Digestive Disease Week San Diego CA May 17-22, 2008     Alcohol Abuse & Dependence Has Big Impact on Cirrhosis in HIV/HCV Coinfection - (05/28/08)   Despite Mucosal CD4+ T Cell Depletion, the Prevalence of GI Symptoms Is Low During Acute and Early HIV-1 Infection - (05/28/08)   Effects of Eltrombopag On Thrombopietin Levels During Antiviral Therapy in HCV Patients with Cirrhosis - (05/21/08)   The Role of Cholesterol On Sustained Virological Response (SVR) in the Treatment of Genotype-1 Infected Hepatitis C (cHC) Patients with Peginterferon Alfa-2a (PEG) and Ribavirin (RBV) - (05/21/08)   Telaprevir, HCV Protease Inhibitor: results from PROVE1 and PROVE2 Studies at DDW - (05/20/08)   A Dramatic Alteration in the Cholesterol Metabolism in An HCV Infected-Liver: the Implications for HCV Infection and Treatment - (05/20/08)   Utility of Serum Biomarker Profiles in Predicting the Treatment Outcome in Chronic Hepatitis C Virus Patients - (05/20/08)   Very Early Viral Response to Treatment of Hepatitis C Virus (HCV) with Pegylated Interferon and Ribavirin: the First 24 Hours - (05/20/08)   A Randomized Trial of Standard vs. Dose-Escalation Dosing of Ribavirin in Combination Therapy for Chronic Hepatitis C Patients with Genotype 1 and High Viral Load - (05/20/08)   Metabolic Factors and Inflammatory Changes Are Responsible for Increased Gamma-Glutamyltranspeptidase Level in Chronic Hepatitis C - (05/20/08)   Effect of Nicotine On Innate Antiviral Pathways and HCV Replication - (05/20/08)   African-American Peg/RBV Response May Be Genetically Impaired: Polymorphism in the Human MHC and the Early Viral Decline During Treatment of HCV - (05/20/08)   Explosion Disrupts Digestive Disease Week Meeting - (05/20/08)   Racial/Ethnic Minorities with Chronic Hepatitis C Virus Infection Have More Severe Fatigue Than White Patients with Chronic Hepatitis C Virus Infection - (05/20/08)   A Dramatic Alteration in the Cholesterol Metabolism in An HCV Infected-Liver: the Implications for HCV Infection and Treatment - (05/20/08)   African-American Peg/RBV Response May Be Genetically Impaired: Polymorphism in the Human MHC and the Early Viral Decline During Treatment of HCV - (05/20/08)   Variants in Interferon-Α Pathway Genes and Response to Treatment of Chronic Hepatitis C - (05/20/08)   Response to Therapy with Pegylated Interferon and Ribavirin in Hispanics with Hepatitis C Compared to Non-Hispanic Whites - (05/20/08)